This work provides practitioners with in-depth, article-by-article analysis of the TRIPS Agreement. For each article it describes the evolution of the provision and its negotiating history, difficulties in its interpretation and application, and the key points practitioners must consider in their work. In addition, it examines the history and context of the Agreement and assesses its likely impact on the future development of the international intellectual property framework.
These books present a coherent description of the facts that will allow for discussion and independent conclusions about policies, politics, and processes.
These books present a coherent description of the facts that will allow for discussion and independent conclusions about policies, politics, and processes.
This work addresses the environmental and developmental impacts of patent protection by focusing on the global agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
This volume aims to offer the reader a rapid understanding of some of these European or international texts which deal with some general and jurisdictional issues and are very important from a practical point of view.
Analyzes the economic contribution of IPRs' underlying features: innovation and access to international technologies.
These are commonly known as free trade agreements or "FTAs", and they are promoted as providing significant economic benefits to signatory countries through the removal or reduction of barriers to trade in goods and services.
The Present Book Deals With Intellectual Property Which Was A Critical Area In The Negotialions.As We All Know Before The Wto, This Important Area Was Dealf By The Paris Agreement (1863), Berne Convection (1886), Marred Agreement (1891), ...
This pamphlet analyses how the aims of the Convention on Biological Diversity (CBD), and its provision for intellectual property rights (IPRs), interact with international trade rules, particularly in the issues of seeds and plant varieties ...
This book is also the ideal companion to any traditional legal casebook on international trade or on international economic law.
This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all.